The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Chronic Kidney Disease Awareness, Prevalence, and Trends among U.S. Adults, 1999 to 2000
Abstract
The incidence of kidney failure treatment in the United States increased 57% from 1991 to 2000. Chronic kidney disease (CKD) prevalence was 11% among U.S. adults surveyed in 1988 to 1994. The objective of this study was to estimate awareness of CKD in the U.S. population during 1999 to 2000 and to determine whether the prevalence of CKD in the United States increased compared with 1988 to 1994. Analysis was conducted of nationally representative samples of noninstitutionalized adults, aged 20 yr and older, in two National Health and Nutrition Examination Surveys conducted in 1988 to 1994 (n = 15,488) and 1999 to 2000 (n = 4101) for prevalence +/- SE. Awareness of CKD is self-reported. Kidney function (GFR), kidney damage (microalbuminuria or greater), and stages of CKD (GFR and albuminuria) were estimated from calibrated serum creatinine, spot urine albumin to creatinine ratio (ACR), age, gender, and race. GFR was estimated using the simplified Modification of Diet in Renal Disease Study equation. Self-reported awareness of weak or failing kidneys in 1999 to 2000 was strongly associated with decreased kidney function and albuminuria but was low even in the presence of both conditions. Only 24.3 +/- 6.4% of patients at GFR 15 to 59 ml/min per 1.73 m(2) and albuminuria were aware of CKD compared with 1.1 +/- 0.3% at GFR of 90 ml/min per 1.73 m(2) or greater and no microalbuminuria. At moderately decreased kidney function (GFR 30 to 59 ml/min per 1.73 m(2)), awareness was much lower among women than men (2.9 +/- 1.6 versus 17.9 +/- 5.9%; P = 0.008). The prevalence of moderately or severely decreased kidney function (GFR 15 to 59 ml/min per 1.73 m(2)) remained stable over the past decade (4.4 +/- 0.3% in 1988 to 1994 and 3.8 +/- 0.4% in 1999 to 2000; P = 0.23). At the same time, the prevalence of albuminuria (ACR >/= 30 mg/g) in single spot urine increased from 8.2 +/- 0.4% to 10.1 +/- 0.7% (P = 0.01). Overall CKD prevalence was similar in both surveys (9% using ACR > 30 mg/g for persistent microalbuminuria; 11% in 1988 to 1994 and 12% in 1999 to 2000 using gender-specific ACR cutoffs). Despite a high prevalence, CKD awareness in the U.S. population is low. In contrast to the dramatic increase in treated kidney failure, overall CKD prevalence in the U.S. population has been relatively stable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Self-citationLevey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., & Eknoyan, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00013 · Cited by 4,615
Self-citationSarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
Self-citationCoresh, J., Astor, B. C., Greene, T., Eknoyan, G., & Levey, A. S. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50007 · Cited by 2,768
Self-citationSerum Creatinine as an Index of Renal Function: New Insights into Old Concepts
Perrone, R. D., Madias, N. E., & Levey, A. S. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.10.1933 · Cited by 1,581
Goodpasture syndrome during the course of a Schönlein-Henoch purpura
Carreras, L., Poveda, R., Bas, J., Mestre, M., Rama, I., & Carrera, M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32799 · Cited by 1,474
Ethnic disparities in diabetic complications in an insured population
Karter, A. J. (2002) · JAMA · doi:10.1001/jama.287.19.2519 · Cited by 840 · cited 1×
“Furthermore, risk of myocardial infarction, at least among people with diabetes, is greater in whites (28).”
BackgroundProjecting the Number of Patients with End-Stage Renal Disease in the United States to the Year 2015
Gilbertson, D. T., Liu, J., Xue, J. L., Louis, T. A., Solid, C. A., Ebben, J. P., & Collins, A. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010112 · Cited by 719
Coresh, J., Astor, B. C., McQuillan, G., Kusek, J., Greene, T., Van Lente, F., & Levey, A. S. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32765 · Cited by 717
Self-citationPredictors of the progression of renal disease in the Modification of Diet in Renal Disease Study
Modification of Diet in Renal Disease Study Group, Hunsicker, L. G., Adler, S., Caggiula, A., England, B. K., Greene, T., Kusek, J. W., Rogers, N. L., Teschan, P. E., & Beck, G. (1997) · Kidney International · doi:10.1038/ki.1997.260 · Cited by 702
Keane, W. F., & Eknoyan, G. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70442-7 · Cited by 591
Coresh, J., Wei, G. L., McQuillan, G., Brancati, F. L., Levey, A. S., Jones, C., & Klag, M. J. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.9.1207 · Cited by 587
Self-citationEknoyan, G., Hostetter, T., Bakris, G. L., Hebert, L., Levey, A. S., Parving, H.-H., Steffes, M. W., & Toto, R. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00826-6 · Cited by 506
Self-citationThe Timing of Specialist Evaluation in Chronic Kidney Disease and Mortality
Kinchen, K. S., Sadler, J., Fink, N., Brookmeyer, R., Klag, M. J., Levey, A. S., & Powe, N. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-6-200209170-00007 · Cited by 458
Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey
Jones, C. A., Francis, M. E., Eberhardt, M. S., Chavers, B., Coresh, J., Engelgau, M., Kusek, J. W., Byrd-Holt, D., Narayan, K. M. V., Herman, W. H., et al. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.31388 · Cited by 444
Self-citationHsu, C.-Y., Lin, F., Vittinghoff, E., & Shlipak, M. G. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000091586.46532.b4 · Cited by 432
Gunter, E. W., Lewis, B. G., & Koncikowski, S. M. (1996) · Cited by 392
Chronic kidney disease and cardiovascular disease in the Medicare population
Collins, A. J., Li, S., Gilbertson, D. T., Liu, J., Chen, S.-C., & Herzog, C. A. (2003) · Kidney International · doi:10.1046/j.1523-1755.64.s87.5.x · Cited by 346
Sample design: Third National Health and Nutrition Examination Survey.
Ezzati, T. M., Massey, J. T., Waksberg, J., Chu, A., & Maurer, K. R. (1992) · PubMed · Cited by 326
Warram, J. H., Gearin, G., Laffel, L., & Krolewski, A. S. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v76930 · Cited by 313
Hsu, C.-Y., Vittinghoff, E., Lin, F., & Shlipak, M. G. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-2-200407200-00007 · Cited by 266
Lewis, J., Agodoa, L., Cheek, D., Greene, T., Middleton, J., O'Connor, D., Ojo, A., Phillips, R., Sika, M., & Wright, J. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.27691 · Cited by 229
Levey, A. S., Coresh, J., Balk, E. M., Kausz, A. T., Levin, A., & Steffes, M. W. (2003) · Annals of Internal Medicine · Cited by 195
Self-citationMcClellan, W. M., Knight, D. F., Karp, H. R., & Brown, W. W. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90197-9 · Cited by 172
McClellan, W. M., Langston, R. D., & Presley, R. J. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000129982.10611.4c · Cited by 149
Management of Patients with Chronic Renal Insufficiency in the Northeastern United States
Kausz, A. T., Khan, S. S., Abichandani, R., Kazmi, W., Obrador, G. T., Ruthazer, R., & Pereira, B. J. G. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1271501 · Cited by 132
Nickolas, T. L., Frisch, G., Opotowsky, A. R., Arons, R. R., & Radhakrishnan, J. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.04.023 · Cited by 111
Muntner, P., Coresh, J., Powe, N. R., & Klag, M. J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000067420.83632.c1 · Cited by 87
Self-citation
Cited by
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725
Self-citationHeart Disease and Stroke Statistics—2010 Update: A Report From the American Heart Association
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., Ferguson, T. B., Ford, E., Furie, K., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192667 · Cited by 5,700
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Self-citationChronic kidney disease: global dimension and perspectives
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M., & Yang, C.-W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60687-x · Cited by 4,383
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
Hill, N. R., Fatoba, S. T., Oke, J. L., Hirst, J. A., O’Callaghan, C. A., Lasserson, D. S., & Hobbs, F. D. R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158765 · Cited by 4,030
Metadata
- Authors
- Coresh, J., Byrd-Holt, D., Astor, B. C., Briggs, J. P., Eggers, P. W., Lacher, D. A., & Hostetter, T. H.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2005-01
- Volume
- 16
- Issue
- 1
- Pages
- 180-188
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2151509478
- Cited by
- 842
- References
- 28
- FWCI
- 28.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.